Expanding $1 Billion Brand Club Fits In J&J Consumer Big Picture
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
J&J consumer sector Chairman Jorge Mesquita says the Tylenol analgesic and cough/cold line is an OTC brand the firm expects to join its $1bn club, which already includes the Neutrogena skin care, Listerine oral care and Johnson's Baby lines.
You may also be interested in...
Tylenol Relaunch Ads Harken To “Trusted” History
In online video ads for Tylenol, the firm says “for everything we do, we know you do so much more.” CFO Dominic Caruso says the ad campaign will reconnect the brand with consumers.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.